reuters.com

Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows ( www.reuters.com )

Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking insulin and other diabetes drugs, according to a study published on Friday....

  • All
  • Subscribed
  • Moderated
  • Favorites
  • random
  • test
  • worldmews
  • mews
  • All magazines